{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:08:10Z","timestamp":1780632490848,"version":"3.54.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency Thailand","doi-asserted-by":"crossref","award":["P-15-50004"],"award-info":[{"award-number":["P-15-50004"]}],"id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Center of Excellence in Clinical Virology of Chulalongkorn University","award":["GCE 59-009-30-005"],"award-info":[{"award-number":["GCE 59-009-30-005"]}]},{"name":"Overseas Research Experience Scholarship for Graduate Students of Chulalongkorn University"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190877","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T19:42:53Z","timestamp":1515699773000},"page":"e0190877","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010\u20132015"],"prefix":"10.1371","volume":"13","author":[{"given":"Nipaporn","family":"Tewawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindumadhav M.","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sompong","family":"Vongpunsawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Webby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9067-5682","authenticated-orcid":true,"given":"Elena A.","family":"Govorkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"issue":"1","key":"ref1","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"AE Fiore","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"ref2","unstructured":"Centers for Diseases Control and Prevention. Influenza antiviral medications: summary for clinicians. [Cited 2017 March 29]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/flu\/pdf\/professionals\/antivirals\/antiviral-summary-clinician-updated.pdf\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/flu\/pdf\/professionals\/antivirals\/antiviral-summary-clinician-updated.pdf<\/ext-link>."},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0042-6822(74)90276-1","article-title":"Characterization of temperature sensitive influenza virus mutants defective in neuraminidase","volume":"61","author":"P Palese","year":"1974","journal-title":"Virology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1743-422X-8-183","article-title":"Positive selection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses","volume":"8","author":"W Li","year":"2011","journal-title":"Virol J"},{"issue":"37","key":"ref5","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins","volume":"285","author":"SJ Gamblin","year":"2010","journal-title":"J Biol Chem"},{"issue":"5912","key":"ref6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase","volume":"303","author":"PM Colman","year":"1983","journal-title":"Nature"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","article-title":"The 2.2 \u00c5 resolution crystal structure of influenza B neuraminidase and its complex with sialic acid","volume":"11","author":"WP Burmeister","year":"1992","journal-title":"EMBO J"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.67.6.2972-2980.1993","article-title":"Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase","volume":"67","author":"PM Colman","year":"1993","journal-title":"J Virol"},{"issue":"17","key":"ref9","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"HL Yen","year":"2006","journal-title":"J Virol"},{"issue":"1 Pt B","key":"ref10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"HT Nguyen","year":"2012","journal-title":"Antivir Ther"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.antiviral.2013.08.023","article-title":"Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance","volume":"100","author":"AJ Burnham","year":"2013","journal-title":"Antiviral Res"},{"issue":"Suppl 1","key":"ref12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/irv.12044","article-title":"Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses","volume":"7","author":"EA Govorkova","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"e66105","DOI":"10.1371\/journal.pone.0066105","article-title":"I222 neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian clade 2.1 highly pathogenic avian influenza A(H5N1) viruses","volume":"8","author":"JL McKimm-Breschkin","year":"2013","journal-title":"PLoS One"},{"key":"ref14","unstructured":"WHO. Weekly epidemiological record (WER). 2012; 87(39):369\u2013380. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/wer\/2012\/wer8739\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/wer\/2012\/wer8739\/en\/<\/ext-link>."},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/irv.12187","article-title":"Peramivir and laninamivir susceptibility of circulating influenza A and B viruses","volume":"8","author":"SK Leang","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2016.06.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014\u20132015","volume":"132","author":"AC Hurt","year":"2016","journal-title":"Antiviral Res"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.antiviral.2012.12.016","article-title":"Influenza antiviral resistance in the Asia-Pacific region during 2011","volume":"97","author":"SK Leang","year":"2013","journal-title":"Antiviral Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2016.11.007","article-title":"The I427T neuraminidase (NA) substitution, located outside the NA active site of an influenza A(H1N1)pdm09 variant with reduced susceptibility to NA inhibitors, alters NA properties and impairs viral fitness","volume":"137","author":"V Tu","year":"2017","journal-title":"Antiviral Res"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"e0175655","DOI":"10.1371\/journal.pone.0175655","article-title":"Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015","volume":"12","author":"N Tewawong","year":"2017","journal-title":"PLoS One"},{"key":"ref20","unstructured":"The WHO GISRS Antiviral Susceptibility Expert Working Group (AVWG). Summary of neuraminidase amino acid substitutions associated with reduced inhibition by neuraminidase inhibitors (NAI). Last updated 21 October 2016. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/influenza\/gisrs_laboratory\/antiviral_susceptibility\/avwg2014_nai_substitution_table.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/influenza\/gisrs_laboratory\/antiviral_susceptibility\/avwg2014_nai_substitution_table.pdf?ua=1<\/ext-link>."},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"E Hoffmann","year":"2001","journal-title":"Arch Virol"},{"issue":"17","key":"ref22","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1073\/pnas.172393399","article-title":"Rescue of influenza B virus from eight plasmids","volume":"99","author":"E Hoffmann","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1073\/pnas.100133697","article-title":"A DNA transfection system for generation of influenza A virus from eight plasmids","volume":"97","author":"E Hoffmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0166-3542(01)00192-9","article-title":"Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay","volume":"53","author":"LV Gubareva","year":"2002","journal-title":"Antiviral Res"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate","volume":"94","author":"M Potier","year":"1979","journal-title":"Anal Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e71401","DOI":"10.1371\/journal.pone.0071401","article-title":"Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate","volume":"8","author":"BM Marathe","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"M Baz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JCM.01732-10","article-title":"The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A\/H3N2 E119V mutant","volume":"49","author":"P Simon","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/AAC.02628-13","article-title":"Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y","volume":"58","author":"AJ Burnham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"45","key":"ref31","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.45.30060","article-title":"Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring","volume":"20","author":"K Little","year":"2015","journal-title":"Euro Surveill"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T14:10:23Z","timestamp":1603635023000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190877"}},"subtitle":[],"editor":[{"given":"Stephen Mark","family":"Tompkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190877","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]}}}